S48G - FDA's GFI # 256 on Animal Drug Compounding - Balancing the Need for FDA-Approved & Compounded Drugs in Veterinary Medicine (Part 1)

Wednesday, February 22, 2023

2:00 PM – 2:50 PM

Location: South Seas F, Level 3

Earn 1 CE Hours

Sponsored By

AMERICAN VETERINARY MEDICAL ASSOCIATION

Presenter(s)

Mike Murphy, DVM, JD, PhD

Director, Division of Animal and Public Health

PDF Handouts

Moderator(s)

Jackie Ott Jaakola

Executive Director
EVERYCAT HEALTH FOUNDATION
Wyckoff, NJ, United States

Learn how to distinguish AMDUCA/Part 530 compounding from compounding from "bulk drug substances" (BDS) and hear about the status of the process for nominating drugs to be compounded from BDS.

Learning Objectives:

Distinguish AMDUCA compounding from compounding starting with bulk drug substances
Understand how to nominate substances to the various lists corresponding to FDA GFI #256
Understand how the finalized USP chapters 795 and 797 may impact compounding by and for veterinarians